Establishment Labs Holdings Inc. (ESTA) Stock Score, Valuation & Financial Research
Establishment Labs Holdings Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 15/100.
Quick answer for ESTA
Establishment Labs Holdings Inc. currently has a Wall Street Score of 15/100. The stored market price is $71.92. Its financial score is 23/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Establishment Labs Holdings Inc. does
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main offi
ESTA financial snapshot
- Wall Street Score:
- 15/100
- Current price:
- $71.92
- Market capitalization:
- $2.12B
- Revenue:
- $245.8M
- Net income:
- $-38.9M
- Free cash flow:
- $-57.6M
- Cash:
- $71.2M
- Total debt:
- $263.7M
- EPS:
- -1.31
- Financial score:
- 23/100
- Valuation score:
- 0/100
- Revenue score:
- 27/100
What stands out
- Reported year-over-year revenue growth is +0.2%.
- Free cash flow is $-57.6M, showing cash burn in the current stored period.
- The balance sheet shows $71.2M of cash versus $263.7M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 23/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research ESTA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.